OptimizeRx Corporation has released a corporate presentation highlighting its role as a leading technology provider in the healthcare community. The presentation outlines the company's focus on enabling engagement between life sciences organizations, physicians, and patients, emphasizing its technology platform that facilitates patient adherence to therapy. OptimizeRx boasts approximately 130 employees across the United States and Croatia, with an average revenue per employee exceeding $700,000. As of May 13, 2025, the company's stock is priced at $11.01, with a market capitalization of around $203.6 million. OptimizeRx is listed on the NASDAQ exchange under the ticker OPRX. You can access the full presentation through the link below.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.